You need treatment.But you don’t want surgery.Is there another way? For some conditions, yes.You now have options that don’t involve cutting, stitching, or hospital stays. Let’s explore how noninvasive procedures can work like surgery—without the surgery. What Is a Noninvasive Procedure? It’s a medical treatment that doesn’t break the skin or enter your body.No scalpels.No […]
Noninvasive Option With Surgical-Level Results Read More »
Glaucoma damages the optic nerve.It can lead to vision loss. One cause is high intraocular pressure (IOP).Another is nerve cell damage inside the eye. Current treatments focus mostly on lowering IOP.But what if a drug could do both? That’s what researchers tested with MN-08.It’s a compound related to memantine. What Is MN-08? MN-08 is based
MN-08 Shows Pressure Reduction, Nerve Protection in Glaucoma Read More »
Enhanced IOP Control with Anti-VEGF and MMC Surgical Therapy Managing intraocular pressure (IOP) is a critical aspect of treating glaucoma and other ocular conditions that threaten vision. Traditional surgical interventions, while effective, often come with complications such as scarring and inflammation. However, combining anti-VEGF (vascular endothelial growth factor) therapy with mitomycin C (MMC) surgical therapy
Improved IOP Control with Anti-VEGF and MMC Surgery Read More »
Innovative Minimally Invasive Glaucoma Treatments in Development Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. Traditional treatments, such as eye drops, laser therapy, and invasive surgeries, have been the mainstay for managing intraocular pressure (IOP). However, these methods often come with limitations, including side effects, compliance issues, and variable efficacy.
Researchers developing ‘minimally invasive’ glaucoma treatments Read More »
Surge in Three Major Eye Diseases Linked to Blindness In recent years, the prevalence of eye diseases leading to blindness has seen a concerning rise. With aging populations, increased screen time, and environmental factors, experts warn that conditions like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are becoming more widespread. Understanding these diseases, their
Cases of ‘three major eye diseases’ linked to blindness surge Read More »
Brandon Capital and Labor’s NRF Invest $40M in Glaucoma Biotech PolyActiva The biotechnology sector continues to attract significant investment as innovative companies push the boundaries of medical science. In a major development, Brandon Capital and Labor’s National Reconstruction Fund (NRF) have jointly invested $40 million in PolyActiva, an Australian biotech firm specializing in glaucoma treatments.
Brandon Capital, Labor’s NRF invest $40m into glaucoma biotech PolyActiava Read More »
Glaucoma Treatment Market to Hit USD 14.1 Billion by 2033 with 5.35% CAGR Growth The global glaucoma treatment market is poised for significant expansion, projected to reach USD 14.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.35%. This growth is fueled by rising prevalence of glaucoma, advancements in treatment options,
Glaucoma Treatment Market Booms to USD 14.1 Billion by 2033: A 5.35% CAGR Forecast Read More »
iStent Infinite Trial: Key Clinical Insights for Glaucoma Treatment Glaucoma remains one of the leading causes of irreversible blindness worldwide, affecting millions of people. While traditional treatments like eye drops, laser therapy, and trabeculectomy have been the mainstay, minimally invasive glaucoma surgeries (MIGS) are revolutionizing patient care. Among these, the iStent Infinite has emerged as
The Residency Report: Clinical insights from the iStent infinite trial Read More »
Early Diagnosis of Childhood Glaucoma with Swept-Source AS-OCT Childhood glaucoma is a rare but serious eye condition that can lead to permanent vision loss if not diagnosed and treated early. Traditional diagnostic methods often fall short in detecting subtle changes in the anterior segment of the eye, especially in young children. However, advancements in imaging
Swept-source AS-OCT aids in early diagnosis of childhood glaucoma Read More »
Dr. Oluwatosin Smith Advocates Early Glaucoma Care at ASCRS 2025 At the prestigious American Society of Cataract and Refractive Surgery (ASCRS) 2025 conference, renowned ophthalmologist Dr. Oluwatosin Smith delivered a compelling keynote address on the critical importance of early glaucoma detection and intervention. With glaucoma being a leading cause of irreversible blindness worldwide, Dr. Smith’s
Copyright Glaucoma Philippines, ©2025
